127 related articles for article (PubMed ID: 37543059)
21. Knockdown of PRDX2 sensitizes colon cancer cells to 5-FU by suppressing the PI3K/AKT signaling pathway.
Xu J; Zhang S; Wang R; Wu X; Zeng L; Fu Z
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28432271
[TBL] [Abstract][Full Text] [Related]
22. Bcl-XL small interfering RNA suppresses the proliferation of 5-fluorouracil-resistant human colon cancer cells.
Zhu H; Guo W; Zhang L; Davis JJ; Teraishi F; Wu S; Cao X; Daniel J; Smythe WR; Fang B
Mol Cancer Ther; 2005 Mar; 4(3):451-6. PubMed ID: 15767554
[TBL] [Abstract][Full Text] [Related]
23. c-Fos regulated by TMPO/ERK axis promotes 5-FU resistance via inducing NANOG transcription in colon cancer.
Gui Y; Qian X; Ding Y; Chen Q; Fangyu Ye ; Ye Y; Hou Y; Yu J; Zhao L
Cell Death Dis; 2024 Jan; 15(1):61. PubMed ID: 38233377
[TBL] [Abstract][Full Text] [Related]
24. ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway.
Yang H; Huebner K; Hampel C; Erlenbach-Wuensch K; Selvamani SB; Shukla V; Geppert CI; Hartmann A; Mahadevan V; Schneider-Stock R
BMC Cancer; 2023 May; 23(1):480. PubMed ID: 37237279
[TBL] [Abstract][Full Text] [Related]
25. FOSL1 transcriptionally regulates PHLDA2 to promote 5-FU resistance in colon cancer cells.
Liu G; Wang H; Ran R; Wang Y; Li Y
Pathol Res Pract; 2023 Jun; 246():154496. PubMed ID: 37178619
[TBL] [Abstract][Full Text] [Related]
26. Extracellular chaperonin 10 augments apoptotic cell death induced by 5-fluorouracil in human colon cancer cells.
Kim K; Yeo SG
Tumori; 2014; 100(6):e230-5. PubMed ID: 25688504
[TBL] [Abstract][Full Text] [Related]
27. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
28. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of lactate dehydrogenase A by microRNA-34a resensitizes colon cancer cells to 5-fluorouracil.
Li X; Zhao H; Zhou X; Song L
Mol Med Rep; 2015 Jan; 11(1):577-82. PubMed ID: 25333573
[TBL] [Abstract][Full Text] [Related]
30. Perifosine enhances the potential antitumor effect of 5-fluorourasil and oxaliplatin in colon cancer cells harboring the PIK3CA mutation.
Morii Y; Tsubaki M; Takeda T; Otubo R; Seki S; Yamatomo Y; Imano M; Satou T; Shimomura K; Nishida S
Eur J Pharmacol; 2021 May; 898():173957. PubMed ID: 33662352
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological targeting of RAD6 enzyme-mediated translesion synthesis overcomes resistance to platinum-based drugs.
Sanders MA; Haynes B; Nangia-Makker P; Polin LA; Shekhar MP
J Biol Chem; 2017 Jun; 292(25):10347-10363. PubMed ID: 28490629
[TBL] [Abstract][Full Text] [Related]
32. Spica Prunellae Extract Enhances Fluorouracil Sensitivity of 5-Fluorouracil-Resistant Human Colon Carcinoma HCT-8/5-FU Cells via TOP2
Fang Y; Yang C; Zhang L; Wei L; Lin J; Zhao J; Peng J
Biomed Res Int; 2019; 2019():5953619. PubMed ID: 31662984
[TBL] [Abstract][Full Text] [Related]
33. Metabotropic glutamate receptor 4-mediated 5-Fluorouracil resistance in a human colon cancer cell line.
Yoo BC; Jeon E; Hong SH; Shin YK; Chang HJ; Park JG
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4176-84. PubMed ID: 15217955
[TBL] [Abstract][Full Text] [Related]
34. Downregulation of lncRNA CCAT1 enhances 5-fluorouracil sensitivity in human colon cancer cells.
Yang C; Pan Y; Deng SP
BMC Mol Cell Biol; 2019 Apr; 20(1):9. PubMed ID: 31039730
[TBL] [Abstract][Full Text] [Related]
35. 5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer.
Ortiz R; Prados J; Melguizo C; Arias JL; Ruiz MA; Alvarez PJ; Caba O; Luque R; Segura A; Aránega A
Int J Nanomedicine; 2012; 7():95-107. PubMed ID: 22275826
[TBL] [Abstract][Full Text] [Related]
36. Activation of the PERK-ATF4 pathway promotes chemo-resistance in colon cancer cells.
Shi Z; Yu X; Yuan M; Lv W; Feng T; Bai R; Zhong H
Sci Rep; 2019 Mar; 9(1):3210. PubMed ID: 30824833
[TBL] [Abstract][Full Text] [Related]
37. MEK5/ERK5 signaling inhibition increases colon cancer cell sensitivity to 5-fluorouracil through a p53-dependent mechanism.
Pereira DM; Simões AE; Gomes SE; Castro RE; Carvalho T; Rodrigues CM; Borralho PM
Oncotarget; 2016 Jun; 7(23):34322-40. PubMed ID: 27144434
[TBL] [Abstract][Full Text] [Related]
38. DUOX2-mediated production of reactive oxygen species induces epithelial mesenchymal transition in 5-fluorouracil resistant human colon cancer cells.
Kang KA; Ryu YS; Piao MJ; Shilnikova K; Kang HK; Yi JM; Boulanger M; Paolillo R; Bossis G; Yoon SY; Kim SB; Hyun JW
Redox Biol; 2018 Jul; 17():224-235. PubMed ID: 29715584
[TBL] [Abstract][Full Text] [Related]
39. Elucidation of underlying molecular mechanism of 5-Fluorouracil chemoresistance and its restoration using fish oil in experimental colon carcinoma.
Rani I; Kumar S; Sharma B; Prasad R; Kaur S; Sharma P; Agnihotri N
Mol Cell Biochem; 2021 Mar; 476(3):1517-1527. PubMed ID: 33392922
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of hydrogen sulfide synthesis reverses acquired resistance to 5-FU through miR-215-5p-EREG/TYMS axis in colon cancer cells.
Chen S; Yue T; Huang Z; Zhu J; Bu D; Wang X; Pan Y; Liu Y; Wang P
Cancer Lett; 2019 Dec; 466():49-60. PubMed ID: 31542354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
